Capricor Therapeutics CAPR
NASDAQ CAPR
$11.22 +2.35 (+26.49%)
At close: Nov 11, 2026 · 4:00 PM EST

Capricor Therapeutics (CAPR) Return on Assets [ROA] (2009 - 2026)

Updated

Capricor Therapeutics (CAPR) posted Return on Assets [ROA] of -36.37% for Q2 2026, up 12.26 percentage points from -48.63% a year earlier but down 3.66 percentage points from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For FY2025, Capricor Therapeutics' Return on Assets [ROA] came in at -39.91%, down 4.60 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +19.82 percentage points (FY2020 to FY2025).
  • In prior years, Capricor Therapeutics' Return on Assets [ROA] was -35.31% in FY2024 (+5.76 pp), -41.07% in FY2023 (+22.75 pp), -63.82% in FY2022 (-8.84 pp) and -54.99% in FY2021 (+4.74 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -70.24% in Q3 2023 to a high of -30.64% in Q4 2024 over five years.
  • On a year-over-year basis, Return on Assets [ROA] increased in six of the last eight quarters, with an average year-over-year change of +6.43 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2024, with a gain of 18.15 percentage points; the weakest was Q3 2023, with a drop of 20.50 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -32.70% (Q1 2026), -42.29% (Q4 2025) and -62.98% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Capricor Therapeutics 515.69 Mn -516.56 Mn - -42.48%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -42.48%
Jun 30, 2026 -37.69%
Mar 31, 2026 -34.20%
Dec 31, 2025 -43.86%
Sep 30, 2025 -62.49%
Jun 30, 2025 -47.85%
Mar 31, 2025 -33.04%
Dec 31, 2024 -30.12%
Sep 30, 2024 -33,768,410.69%
Jun 30, 2024 -50,516,416.26%
Mar 31, 2024 -40,963,629.27%
Dec 31, 2023 -46,214,924.36%
Sep 30, 2023 -69,535,982.99%
Jun 30, 2023 -57,901,180.34%
Mar 31, 2023 -55,626,693.93%
Dec 31, 2022 -55,592,096.51%
Sep 30, 2022 -35,756,530.49%
Jun 30, 2022 -32,560,262.31%
Mar 31, 2022 -37,688,659.51%
Dec 31, 2021 -47,429,396.77%
API Access

Capricor Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CAPR&period=max&api_key=YOUR_API_KEY